Gilde Healthcare Partners raises growth capital fund dedicated to healthcare services - Gilde Healthcare

Menu
Menu
Home

Gilde Healthcare Partners raises growth capital fund dedicated to healthcare services

December 9, 2009

Utrecht, The Netherlands – Gilde Healthcare Partners (Gilde), a European private equity firm specializing in healthcare, today announced the launch of a new growth capital fund, Gilde Healthcare Services. The fund will invest in specialized clinics, providers of elderly care, prevention, screening and other fast growing healthcare services in The Netherlands and surrounding countries. The fund addresses the shortfall in bank finance in the healthcare sector and will provide growth capital to fast growing healthcare services companies. Apart from the new fund, dedicated to healthcare services, Gilde manages two healthcare technology funds.

Gilde Healthcare Services is one of the few European private equity funds raised in 2009. The fund is backed by a mix of institutional investors, family offices and private investors. Gilde is in advanced talks with additional investors and expects the fund size to exceed EUR 50 million in the course of 2010.

“We believe this successful fundraising in the current economic climate is a validation of our strategy. With our hands-on, specialized investment approach we will facilitate the growth of a variety of healthcare service companies.”

said Jasper van Gorp, Investment Director.

“The healthcare sector is transforming rapidly and via Gilde Healthcare Services we provide investors a unique opportunity to participate in fast growing healthcare services.”

About Gilde Healthcare Partners
 
Gilde Healthcare Partners is headquartered in Utrecht, The Netherlands and manages EUR 300 million (USD 450 million) in three investment funds. Gilde’s healthcare technology funds, Healthcare I and II, invest venture capital in therapeutics, diagnostics, medical technologies and biotech. The newly raised Gilde Healthcare Services I fund provides growth capital to healthcare services companies. Gilde Healthcare Partners is a successful builder of healthcare businesses across Europe. By investing in companies with clear deliverable business models, Gilde applies its financial resources, partner expertise and business network to create significant value for both its investors and the entrepreneurs it backs.
 
Contact
Gilde Healthcare Partners 
Jasper van Gorp
Investment Director Healthcare Services
+31(0)30-2192528 
vangorp@gildehealthcare.com
www.gildehealthcare.nl

More news

Gilde Healthcare company SynOx Therapeutics announces Board Chair transition to align with advancing Regulatory and Commercialization Strategy

SynOx Therapeutics Limited (“SynOx”), a late-stage clinical biopharmaceutical company developing of emactuzumab for Tenosynovial Giant Cell Tumours (TGCT), today announced the execution of a planned and orderly transition of its board chair position. Philip Astley-Sparke...
April 1, 2025

Gilde Healthcare company SpliceBio announces first patient dosed in Phase 1/2 ASTRA study of SB-007, a Dual-AAV Gene Therapy for Stargardt Disease

SB-007 addresses the root cause of Stargardt disease with the potential to treat all patients across all ABCA4 mutations SB-007 is the first dual AAV gene therapy in clinical development for Stargardt disease   SpliceBio,...
March 13, 2025

Gilde Healthcare participates in $65 Million financing of Microtransponder to enhance Vivistim adoption for Chronic Stroke Recovery

MicroTransponder®, Inc, today announces a $65 million Series F financing round. MicroTransponder is a fast growing commercial stage stroke company with the FDA-approved Vivistim® Paired VNS™ System. Gilde Healthcare joins the round as new investor,...
March 12, 2025